{"product_id":"custom-orthotics-profitability","title":"How Increase Profits For Custom Orthotics Provider?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eCustom Orthotics Provider Strategies to Increase Profitability\u003c\/h2\u003e\n\u003cp\u003eMost Custom Orthotics Provider clinics can sustain an EBITDA margin between 45% and 55% by focusing on utilization and pricing tiers Your initial model shows a 2026 EBITDA of $832,000 on $162 million in revenue, resulting in a 513% margin This guide details seven strategies to increase capacity utilization-the primary profit lever-and reduce variable costs, which are projected to decrease from 150% to 120% of revenue by 2030 The goal is to maximize revenue per provider hour while managing the fixed overhead of $10,050 per month\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Strategies to Increase Profitability of \u003c\/span\u003eCustom Orthotics Provider\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eStrategy\u003c\/th\u003e\n\u003cth\u003eProfit Lever\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eExpected Impact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eOptimize Tiered Pricing\u003c\/td\u003e\n\u003ctd\u003ePricing\u003c\/td\u003e\n\u003ctd\u003eIncrease the price differential between Senior Podiatrist ($550 AOV) and Junior Podiatrist ($350 AOV) services.\u003c\/td\u003e\n\u003ctd\u003eBetter capture willingness-to-pay segments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eMaximize Provider Capacity\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eFocus marketing to lift utilization from 65% (Senior) and 50% (Biomechanist) toward 85% targets.\u003c\/td\u003e\n\u003ctd\u003eIncreases revenue generated per fixed labor cost.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eNegotiate Lab Fees Down\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eUse increasing volume (3,228 treatments in 2026) to negotiate Lab Fabrication Fees down to 100% of revenue by Year 5.\u003c\/td\u003e\n\u003ctd\u003eReduces COGS percentage, directly boosting gross margin.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eShift Volume to Junior Staff\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eSystematically shift routine follow-ups to Junior Podiatrists ($350 AOV) and Clinical Orthotists ($400 AOV).\u003c\/td\u003e\n\u003ctd\u003eFrees up high-cost Senior Podiatrists ($550 AOV) for higher-value work.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eControl Fixed Overhead\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eMaintain fixed costs at $10,050 per month while revenue scales from $162 million to $929 million.\u003c\/td\u003e\n\u003ctd\u003eDramatically lowers fixed costs as a percentage of revenue.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eReduce Acquisition Costs\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eImprove referral networks and patient retention to cut Patient Acquisition Marketing costs from 50% (2026) to 30% (2030).\u003c\/td\u003e\n\u003ctd\u003eSaves 20 points of revenue currently spent on marketing.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eLeverage Technology Investment\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eEnsure $25,000 3D Scanning System and $15,000 Gait Platform are fully utilized to justify cost.\u003c\/td\u003e\n\u003ctd\u003eJustifies capital expenditure and enhances service quality\/throughput.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the true blended contribution margin per orthotic treatment?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou're looking at a negative contribution margin because total variable costs are projected at \u003cstrong\u003e230%\u003c\/strong\u003e of your revenue, which means you lose money on every service before accounting for fixed overhead; understanding these deep structural costs is why you need to review \u003ca href=\"\/blogs\/operating-costs\/custom-orthotics\"\u003eWhat Are The Operating Costs Of A Custom Orthotics Provider?\u003c\/a\u003e. If the weighted average price for a Custom Orthotics Provider hits \u003cstrong\u003e$50,260\u003c\/strong\u003e in 2026, the variable cost alone hits \u003cstrong\u003e$115,598\u003c\/strong\u003e, showing this model is defintely unsustainable as structured.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVariable Cost Shock\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTotal variable costs equal \u003cstrong\u003e230%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eCOGS is listed at \u003cstrong\u003e150%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eAdditional variable expenses are \u003cstrong\u003e80%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eThe resulting contribution margin is \u003cstrong\u003e-130%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eActionable Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImmediately re-evaluate the \u003cstrong\u003e150%\u003c\/strong\u003e COGS component.\u003c\/li\u003e\n\u003cli\u003ePricing must increase by at least \u003cstrong\u003e$65,338\u003c\/strong\u003e per unit.\u003c\/li\u003e\n\u003cli\u003eFocus on high-value patient segments first.\u003c\/li\u003e\n\u003cli\u003eReduce variable expenses below \u003cstrong\u003e100%\u003c\/strong\u003e quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow quickly can we raise provider utilization to 80% across the board?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou need to hit \u003cstrong\u003e80% utilization\u003c\/strong\u003e across all providers quickly, but the immediate focus must be on maximizing the output of your existing, highly capable Senior Podiatrists before you even look at adding overhead; this is the core financial lever, as detailed in guides like \u003ca href=\"\/blogs\/how-to-open\/custom-orthotics\"\u003eHow To Launch Custom Orthotics Provider Business?\u003c\/a\u003e. If onboarding takes 14+ days, churn risk rises, so operational speed matters defintely.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOptimize Current Capacity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMaximize patient throughput now.\u003c\/li\u003e\n\u003cli\u003eReduce scheduling lag time.\u003c\/li\u003e\n\u003cli\u003eEnsure 3D scanning tech is fast.\u003c\/li\u003e\n\u003cli\u003eTarget \u003cstrong\u003e80% utilization\u003c\/strong\u003e first.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapacity Reality Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSenior Podiatrists start at \u003cstrong\u003e650%\u003c\/strong\u003e in 2026.\u003c\/li\u003e\n\u003cli\u003eThis capacity must be leveraged first.\u003c\/li\u003e\n\u003cli\u003eHiring adds significant fixed overhead.\u003c\/li\u003e\n\u003cli\u003eDon't add staff until 80% is locked.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre our tiered pricing structures maximizing revenue across different staff levels?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou need to confirm if the \u003cstrong\u003e$150 price gap\u003c\/strong\u003e between the Senior Podiatrist service at \u003cstrong\u003e$550\u003c\/strong\u003e and the Clinical Orthotist service at \u003cstrong\u003e$400\u003c\/strong\u003e is optimized for volume and margin, which directly impacts how much a Custom Orthotics Provider owner makes, as detailed in \u003ca href=\"\/blogs\/how-much-makes\/custom-orthotics\"\u003eHow Much Does A Custom Orthotics Provider Owner Make?\u003c\/a\u003e. Honestly, this $150 difference must clearly signal superior perceived value to capture the top tier without pushing too many patients toward the lower-priced option due to sticker shock.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eValue Gap Risk Assessment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe $550 price point requires a \u003cstrong\u003e37.5% premium\u003c\/strong\u003e over the $400 service.\u003c\/li\u003e\n\u003cli\u003eMap current patient mix to see if high-value chronic cases default to $400.\u003c\/li\u003e\n\u003cli\u003eIf the Senior Podiatrist's diagnosis time is identical, the price gap is hard to justify.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises, regardless of the price tier.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTesting Price Elasticity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTest bundling advanced 3D scanning only with the $550 tier for 90 days.\u003c\/li\u003e\n\u003cli\u003eRun a pilot where the $400 service includes a 30-day follow-up check-in, defintely.\u003c\/li\u003e\n\u003cli\u003eThe goal is pushing \u003cstrong\u003eat least 35%\u003c\/strong\u003e of new patients into the top tier.\u003c\/li\u003e\n\u003cli\u003eAnalyze if athletes will pay the $150 difference for injury prevention guarantees.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhere can we aggressively cut the largest variable expense, Lab Fabrication Fees?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe biggest variable cost lever for the Custom Orthotics Provider is aggressively managing Lab Fabrication Fees, which start at \u003cstrong\u003e120% of revenue in 2026\u003c\/strong\u003e and must drop to \u003cstrong\u003e100% by 2030\u003c\/strong\u003e to achieve necessary margin expansion, as detailed in this analysis on \u003ca href=\"\/blogs\/startup-costs\/custom-orthotics\"\u003eHow Much To Start A Custom Orthotics Provider?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStarting Cost Shock\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLab fees consume \u003cstrong\u003e120% of revenue\u003c\/strong\u003e based on the 2026 projection.\u003c\/li\u003e\n\u003cli\u003eThis means every dollar of service revenue costs $1.20 in direct fabrication.\u003c\/li\u003e\n\u003cli\u003eThis high initial cost defintely limits cash flow for growth initiatives.\u003c\/li\u003e\n\u003cli\u003eImmediate action required: secure volume commitments to renegotiate rates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Expansion Goal\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe goal is reducing fees to \u003cstrong\u003e100% of revenue by 2030\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAchieving this 20% reduction is the primary lever for profitability.\u003c\/li\u003e\n\u003cli\u003eFocus on increasing patient utilization rates to drive down the unit cost.\u003c\/li\u003e\n\u003cli\u003eThis reduction translates directly into improved gross margin dollars per device.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eMaximizing provider utilization, targeting levels above 80%, is the single most critical lever for achieving sustainable EBITDA margins between 45% and 55%.\u003c\/li\u003e\n\n\u003cli\u003eAggressively negotiating Lab Fabrication Fees downward from 120% to 100% of revenue is essential for immediate and long-term margin expansion.\u003c\/li\u003e\n\n\u003cli\u003eOptimize revenue capture by implementing tiered pricing structures that clearly differentiate service values across Senior Podiatrists and Junior staff.\u003c\/li\u003e\n\n\u003cli\u003eShifting routine volume to lower-cost staff members frees up high-value provider time, maximizing revenue per hour across the entire practice.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 1\n: \u003cspan style=\"color: #126CFF;\"\u003eOptimize Tiered Pricing\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWiden Price Gaps\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eStop leaving money on the table by keeping your price tiers too close together. The current \u003cstrong\u003e$200\u003c\/strong\u003e spread between the Senior Podiatrist's \u003cstrong\u003e$550\u003c\/strong\u003e Average Order Value (AOV) and the Junior Podiatrist's \u003cstrong\u003e$350\u003c\/strong\u003e AOV leaves revenue potential untapped. Price segmentation must defintely reflect perceived value difference. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDefine Current Tiers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour current pricing structure rests on two distinct service values, which define your segments. Senior Podiatrist services generate an \u003cstrong\u003e$550\u003c\/strong\u003e AOV, while Junior Podiatrist services bring in \u003cstrong\u003e$350\u003c\/strong\u003e AOV. This $200 difference is your starting point for segmentation analysis. \u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSenior AOV: $550\u003c\/li\u003e\n\u003cli\u003eJunior AOV: $350\u003c\/li\u003e\n\u003cli\u003eCurrent Gap: $200\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eExpand Price Separation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIncrease the price differential to better segment patients based on need and ability to pay. If you move the Senior AOV to \u003cstrong\u003e$650\u003c\/strong\u003e while holding the Junior AOV at \u003cstrong\u003e$350\u003c\/strong\u003e, you create a \u003cstrong\u003e$300\u003c\/strong\u003e spread. That's \u003cstrong\u003e50%\u003c\/strong\u003e more margin capture on the premium service. \u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTarget Senior AOV increase: $100+\u003c\/li\u003e\n\u003cli\u003eFocus on perceived complexity\u003c\/li\u003e\n\u003cli\u003eDon't fear sticker shock\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eConnect Pricing to Staffing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAs you shift routine volume to Junior Podiatrists, the Senior Podiatrist's \u003cstrong\u003e$550\u003c\/strong\u003e AOV must become a much higher anchor price. If the gap remains small, you won't incentivize clients to upgrade or justify the opportunity cost of using your most expensive clinical resource. \u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 2\n: \u003cspan style=\"color: #126CFF;\"\u003eMaximize Provider Capacity\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eHit 85% Utilization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou need marketing to close the gap between current capacity use and the 85% goal. In 2026, Senior Podiatrists ran at \u003cstrong\u003e65%\u003c\/strong\u003e utilization, and Sports Biomechanists only hit \u003cstrong\u003e50%\u003c\/strong\u003e. Closing this gap means significantly more billable hours without hiring new staff, directly boosting revenue from existing fixed overhead. That's smart scaling.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapacity Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eUtilization measures how much of a provider's available time is actually booked. To calculate the potential revenue lift, you need the maximum available monthly slots multiplied by the current utilization rate. For example, if a Senior Podiatrist has 100 slots and is at 65%, that's 65 billable treatments. We must drive that number up to \u003cstrong\u003e85\u003c\/strong\u003e slots.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOptimize Staff Mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDon't just push more volume; push the right volume to the right provider. Shifting routine follow-ups from the \u003cstrong\u003e$550\u003c\/strong\u003e Senior Podiatrist to a \u003cstrong\u003e$350\u003c\/strong\u003e Junior Podiatrist frees up high-value time. If you can move 10 visits monthly this way, you capture $2,000 more margin without needing extra marketing spend. That's efficient scheduling.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eThe Cost of Idle Time\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIdle provider time is pure margin destruction, especially when fixed costs are \u003cstrong\u003e$10,050\u003c\/strong\u003e monthly. If the Sports Biomechanist stays stuck at 50% utilization, you are paying full overhead for half the output. That lost potential means you need significantly more new patient acquisition just to cover existing fixed expenses. It's a hidden drag.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 3\n: \u003cspan style=\"color: #126CFF;\"\u003eNegotiate Lab Fees Down\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Lab Fees Now\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou defintely need to use your growing treatment volume to force down the cost of making the physical orthotics. Right now, lab fabrication costs are \u003cstrong\u003e120% of revenue\u003c\/strong\u003e, which you can't sustain. Your goal is to get that cost down to \u003cstrong\u003e100%\u003c\/strong\u003e by Year 5, using the \u003cstrong\u003e3,228 treatments\u003c\/strong\u003e projected for 2026 as leverage.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat Lab Fees Cover\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLab Fabrication Fees cover the actual manufacturing of the custom orthotics after the podiatrist scans the foot. Currently, this cost sits at \u003cstrong\u003e120%\u003c\/strong\u003e of the revenue generated from the treatment. To estimate the real dollar impact, you need the total number of treatments multiplied by the cost per unit from the lab partner.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCovers materials and labor for fabrication.\u003c\/li\u003e\n\u003cli\u003eCost is currently above revenue per unit.\u003c\/li\u003e\n\u003cli\u003eNeeds volume-based discounts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eNegotiating Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eVolume is your main negotiating chip here. By scaling to \u003cstrong\u003e3,228 treatments\u003c\/strong\u003e in 2026, you gain serious market power with your supplier. Aim to cut the fee structure down to \u003cstrong\u003e100%\u003c\/strong\u003e of revenue by Year 5. Don't accept tiered pricing that doesn't reflect your commitment; push for fixed cost reduction per unit.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eUse 2026 volume as negotiation anchor.\u003c\/li\u003e\n\u003cli\u003eTarget \u003cstrong\u003e100%\u003c\/strong\u003e cost-to-revenue ratio.\u003c\/li\u003e\n\u003cli\u003eAvoid paying for capacity you don't use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eThe Break-Even Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you fail to hit \u003cstrong\u003e100%\u003c\/strong\u003e lab cost parity by Year 5, you are effectively paying someone else to make your product at a loss. That \u003cstrong\u003e20%\u003c\/strong\u003e gap must be closed by contract renewal, or you'll need to find a new manufacturing partner who can handle the volume affordably.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 4\n: \u003cspan style=\"color: #126CFF;\"\u003eShift Volume to Junior Staff\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTiered Capacity Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReallocating routine follow-ups from Senior Podiatrists ($550 AOV) to Junior Podiatrists ($350 AOV) immediately improves your effective margin per hour. This shift frees up \u003cstrong\u003eSenior Podiatrist\u003c\/strong\u003e capacity to handle higher-value procedures, directly increasing the practice's overall revenue ceiling without immediate hiring costs.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Gap Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMisallocating time creates a quantifiable revenue gap you must track daily. If a Senior Podiatrist handles a case better suited for a Clinical Orthotist ($400 AOV), you lose potential revenue. You need clear inputs tracking case complexity against provider tier to stop this leakage. Here's the quick math:\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSenior AOV: \u003cstrong\u003e$550\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eJunior AOV: \u003cstrong\u003e$350\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eLost revenue potential per case: \u003cstrong\u003e$200\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTriage Protocol\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEstablish strict intake rules to defintely route simpler cases away from your highest-cost providers. The biggest mistake is letting scheduling defaults dictate workflow, which keeps expensive staff busy with low-return work. If patient onboarding takes 14+ days due to bottlenecks, patient satisfaction will drop, and churn risk rises fast.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eRoute simple follow-ups to Juniors.\u003c\/li\u003e\n\u003cli\u003eUse Orthotists for standard device checks.\u003c\/li\u003e\n\u003cli\u003eProtect Senior time for complex diagnoses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapacity Protection\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis volume shift is critical for scaling profitably toward the \u003cstrong\u003e85% utilization\u003c\/strong\u003e target mentioned in capacity planning. By reserving the $550 AOV slot only for cases that require that expertise, you maximize the value extracted from your most expensive human capital. It's about ensuring every provider operates at their highest possible billing rate.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 5\n: \u003cspan style=\"color: #126CFF;\"\u003eControl Fixed Overhead\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLock Fixed Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eKeep your \u003cstrong\u003e$10,050\u003c\/strong\u003e monthly fixed overhead locked down while revenue jumps from \u003cstrong\u003e$162M\u003c\/strong\u003e to \u003cstrong\u003e$929M\u003c\/strong\u003e. This strategy creates massive operating leverage, crushing fixed costs as a percentage of sales. It's the fastest way to boost margins when volume explodes.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat $10K Covers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$10,050\u003c\/strong\u003e monthly spend covers core administrative functions that don't scale directly with patient volume. Think rent for the clinic space, core software subscriptions, and essential administrative salaries. You need quotes for lease agreements and software contracts to set this baseline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAvoid Cost Creep\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDon't let growth inflate your baseline expenses. Resist adding non-essential staff or upgrading office space prematurely. If onboarding takes 14+ days, churn risk rises, but hiring too fast inflates fixed costs unnecessarily. Keep the team lean until utilization hits \u003cstrong\u003e85%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eWhen revenue hits \u003cstrong\u003e$929M\u003c\/strong\u003e against fixed costs of \u003cstrong\u003e$10,050\u003c\/strong\u003e, your overhead ratio becomes negligible, maximizing profit capture from every new patient treatment. This leverage is critical for long-term valuation. It's a defintely powerful position.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 6\n: \u003cspan style=\"color: #126CFF;\"\u003eReduce Acquisition Costs\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Acquisition Costs Now\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must aggressively shift focus from paid advertising to organic growth to hit the \u003cstrong\u003e30% PAM cost target by 2030\u003c\/strong\u003e. This operational shift cuts the largest controllable expense line item, moving \u003cstrong\u003e20 points of revenue\u003c\/strong\u003e back to the bottom line.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePAM Cost Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003ePatient Acquisition Marketing (PAM) covers all spend to bring in a new patient, like digital ads or physician outreach. In 2026, this spend eats up \u003cstrong\u003e50% of revenue\u003c\/strong\u003e. Inputs include total marketing spend divided by total new patients seen. We need to track cost per acquisition precisely.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack spend vs. new patient volume.\u003c\/li\u003e\n\u003cli\u003eMonitor referral source quality.\u003c\/li\u003e\n\u003cli\u003eCalculate cost per referred patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDriving Organic Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo cut PAM from 50% down to \u003cstrong\u003e30%\u003c\/strong\u003e, focus on patient satisfaction driving word-of-mouth referrals. High retention means fewer dollars spent replacing lost customers. If onboarding takes 14+ days, churn risk defintely rises, stalling progress toward the 2030 goal.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIncentivize physician referrals strongly.\u003c\/li\u003e\n\u003cli\u003eImprove post-fitting orthotic check-ins.\u003c\/li\u003e\n\u003cli\u003eTarget 90%+ patient satisfaction scores.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eImpact of Cost Reduction\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReducing PAM by \u003cstrong\u003e20 percentage points\u003c\/strong\u003e generates massive cash flow improvement, especially as revenue scales toward \u003cstrong\u003e$929 million\u003c\/strong\u003e. That difference funds capital investment or dramatically improves EBITDA margins faster than any other lever you control right now.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 7\n: \u003cspan style=\"color: #126CFF;\"\u003eLeverage Technology Investment\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eJustify Tech Spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou spent \u003cstrong\u003e$40,000\u003c\/strong\u003e on scanning and gait tech; now you must prove it drives volume or quality improvement. Utilization directly impacts the payback period for these fixed assets, especially as you scale toward \u003cstrong\u003e3,228 treatments\u003c\/strong\u003e in 2026. Don't let high-cost equipment sit idle.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTrack Asset Throughput\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe \u003cstrong\u003e$25,000 3D Scanning System\u003c\/strong\u003e and \u003cstrong\u003e$15,000 Gait Platform\u003c\/strong\u003e are critical capital expenditures (CapEx) for precision diagnosis. These tools must be integrated into every patient workflow to defintely justify the \u003cstrong\u003e$40,000\u003c\/strong\u003e initial outlay. Utilization rates determine how quickly this investment pays back through better service delivery.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack usage per provider daily.\u003c\/li\u003e\n\u003cli\u003eLink usage to patient throughput.\u003c\/li\u003e\n\u003cli\u003eEnsure 100% scanning for new patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDrive Utilization Rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003ePoor utilization means you are paying high fixed costs for low returns. To maximize value, tie scanner time directly to high-value procedures, like the Senior Podiatrist's \u003cstrong\u003e$550 AOV\u003c\/strong\u003e service. If utilization lags, consider leasing options or adding a dedicated technician to drive throughput.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSchedule tech time aggressively.\u003c\/li\u003e\n\u003cli\u003eReview utilization vs. \u003cstrong\u003e85%\u003c\/strong\u003e target.\u003c\/li\u003e\n\u003cli\u003eAvoid underutilization decay.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eConnect Tech to Scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf these tools aren't fully used, they become a drag on your margin, especially when fixed costs of \u003cstrong\u003e$10,050 per month\u003c\/strong\u003e are supposed to shrink as a percentage of revenue. Technology must enable volume, or it just inflates your cost basis.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303775052019,"sku":"custom-orthotics-profitability","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/custom-orthotics-profitability.webp?v=1782680390","url":"https:\/\/financialmodelslab.com\/products\/custom-orthotics-profitability","provider":"Financial Models Lab","version":"1.0","type":"link"}